35 results about "Obstructive emphysema" patented technology

The invention relates to new pharmacological effects of a compound pinocembrin and an application of pinocembrin to preparation of products for preventing, relieving and / or treating pulmonary hypertension and complications thereof. Pinocembrin has the beneficial effects that pinocembrin has the pharmacological effects of relaxing pulmonary arteries, reducing the pulmonary artery pressure, protecting pulmonary vessels from injuries caused by pulmonary hypertension, restoring lung tissue functions, repairing heart and liver injuries, alleviating right ventricular hypertrophy and enlargement, improving heart failure and liver functions, obviously reducing the mortality of animals with pulmonary hypertension and preventing and treating pulmonary hypertension and complications thereof; pinocembrin is an active monomer separated from a natural product propolis, achieves complete synthesis at present, has good application and development prospects, is an ideal compound for treating pulmonary hypertension and complications thereof and can be applied to preparation of the products for preventing, relieving and / or treating pulmonary hypertension and complications thereof, such as chronic obstructive emphysema, chronic pulmonary heart diseases, right heart failure and liver function injuries.

The invention provides a traditional Chinese medicine composition for treating chronic obstructive pulmonary emphysema. The traditional Chinese medicine composition comprises gecko, semen coicis, radix pseudostellariae, liquorice, rhizoma polygonati, schisandra chinensis, fenugreek, caulis spatholobi, turmeric, seabuckthorn, aleppo avens, cynanchum glaucescens, fructus forsythiae, herba inulae, herba ephedra, myristica fragrans, cordyceps sinensis, fructus aristolochiae, semen euryales, kelp, radix curcumae, pericarpium citri reticulatae, resina liquidamberis, rhizoma alpiniae officinarum, agilawood, rhizoma anemarrhenae, polygonum cuspidatum and caulis sargentodoxae. The traditional Chinese medicine composition can regulate lung functions of a patient, improve inherent antiviral ability, treat both symptoms and root causes, can control the illness fundamentally, defer the progression of the illness and treat the illness, and has the advantages that the traditional Chinese medicine composition is good in curative effect, takes effect rapidly, causes no injuries to a human body, does not result in tolerance, has no toxic or side effects, and the illness is not recurrent compared with western medicine.

The invention discloses the drug of treating the nasal over-secretion and chronic obstructive emphysema, at the mean time, provides the drug compositions of treating the nasal over-secretion and chronic obstructive emphysema, which are aerosol, powder cloud agent, naristillae and spray. In the invention, the compositions, which are introduced quaternary ammonium group on the basis of penehyclidine hydrochloride, can't permeate membrane and enter into the circulatory system and central, so it can be used in treating the chronic obstructive emphysema. Besides, due to the low absorptivity in themucous membrane position, the said new compositions are extended the resistance time at local, so it can be used in treating the chronic obstructive emphysema and coryza.

The invention discloses a Chinese medicine compound composition for treating pneumoconiosis and pulmonary fibrosis and a preparation method thereof. The Chinese medicine compound composition consists of 8-30 parts of Rhodiola rosea, 1-4 parts of Manjing ointment, 2-2 parts of Cordyceps sinensis 6 parts, 1~4 parts of Ganoderma lucidum, 1~4 parts of Strawberry (Oriental), 5~20 parts of Fritillaria, 3~10 parts of Snow Lotus, 1~4 parts of Aster, 3~10 parts of Arzhong, 1 part of Tibetan Comfrey ~4 servings made. The results show that the traditional Chinese medicine compound composition for treating pneumoconiosis and pulmonary fibrosis provided by the present invention has rigorous medication, scientific and reasonable proportioning, has the functions of invigorating lung qi, improving immune function, resolving phlegm and dispelling stagnation, relieving cough and asthma, and improving lung function. Ventilation function and other functions have a strong effect on the respiratory system such as bronchitis, obstructive emphysema, pneumoconiosis, etc., and have high safety and low side effects. At the same time, the preparation method provided by the invention has stable quality, high content of extracted active ingredients, strong operability, and is suitable for large-scale industrial production.

The invention discloses a respiratory muscle training device for obstructive emphysema. Including the bottom plate, the upper surface of the bottom plate is fixedly connected with two symmetrical limit strips, the upper surface of the bottom plate is limited and slidably connected with a slider, the upper surface of the slider is provided with a foot support baffle, two The opposite surfaces of the limiting bars are all fixedly connected with the limiting baffles, the opposite surfaces of the limiting baffles and the slider are fixedly connected with extension springs, and the sides of the sliders are fixedly connected with sliding bars, and the sliding bars A support column is fixedly connected to the upper surface of the end away from the slider, and a groove is opened on the surface of the rotating supporting plate near the bottom, and the surface of the support column is rotatably connected with the surface of the support column through the groove. In the present invention, through the cooperative use of the above-mentioned structures, it is difficult to combine physical training with respiratory muscle training in the actual use process because the traditional device only performs one-way sit-up exercise training or single breathing training. question.